Skip to content

Drug interactions

Aprepitant + Eslicarbazepine

Severity: Moderate

Aprepitant and Eslicarbazepine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine is a weak to moderate CYP3A4 inducer and may lower aprepitant concentrations. This could reduce antiemetic effect.

What this interaction means in plain words

Aprepitant and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Aprepitant belongs to Gastrointestinal Tract; Eslicarbazepine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Eslicarbazepine induces CYP3A4, increasing aprepitant metabolism.

What to do

Monitor for breakthrough nausea and vomiting and add rescue antiemetics if control is inadequate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Eslicarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Eslicarbazepine?

MediHelp rates the interaction as moderate. Aprepitant and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eslicarbazepine is a weak to moderate CYP3A4 inducer and may lower aprepitant concentrations. This could reduce antiemetic effect.

How serious is the interaction between Aprepitant and Eslicarbazepine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for breakthrough nausea and vomiting and add rescue antiemetics if control is inadequate.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in